PHARMALIJN
0860.097.218 · rovalta.com · 23/09/2026
ACTIVE
PHARMALIJN
Financial year 2025 · closed on 31/12/2025
Net result
34,5 k €
+21.2% YoY
Gross margin
48,3 k €
+22.5% YoY
Equity
748,3 k €
+4.8% YoY
Overview
What does PHARMALIJN do?
PHARMALIJN is a Private limited company incorporated in 2003. Its main activity is: Activities of holding companies. Its registered office is in Schilde.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0860.097.218
Incorporation
14/08/2003
Legal form
Private limited company
Registered office
Fortsteenweg 9
2970 Schilde · FlandreSee on map
2970 Schilde · FlandreSee on map
Contributed capital
18 550,00 €
Latest accounts
31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||
| Gross margin | 48,3 k € | +22.5% | 39,5 k € | +19.3% | 33,1 k € | -17.2% | 39,9 k € | -3.8% | 41,5 k € | +43327% | -96 € | -100% | 43,2 k € | +432% | -13 k € | +29.6% | -18,4 k € | -173% | 25,4 k € | -45.2% | 46,3 k € | +167% | 17,3 k € | +184% | -20,7 k € | -143% | 47,8 k € | +45.4% | 32,9 k € | -35.3% | 50,8 k € | +20.1% | 42,3 k € | -14.0% | 49,2 k € |
| EBITDA | 47,8 k € | +22.7% | 39 k € | +20.3% | 32,4 k € | +10.3% | 29,3 k € | -28.5% | 41 k € | +42835% | -96 € | -100% | 43,2 k € | +384% | -15,2 k € | +26.3% | -20,6 k € | -193% | 22,1 k € | -47.8% | 42,3 k € | +187% | 14,8 k € | +169% | -21,4 k € | -146% | 46,9 k € | +47.4% | 31,8 k € | -36.7% | 50,3 k € | +20.3% | 41,8 k € | -14.4% | 48,8 k € |
| Operating result | 47,8 k € | +22.7% | 39 k € | +20.3% | 32,4 k € | -13.4% | 37,4 k € | -2.4% | 38,3 k € | +1463% | -2,8 k € | -107% | 40,5 k € | +322% | -18,2 k € | +30.4% | -26,1 k € | -261% | 16,2 k € | -55.8% | 36,7 k € | +173% | 13,4 k € | +162% | -21,8 k € | -152% | 41,7 k € | +57.5% | 26,5 k € | -40.7% | 44,7 k € | +23.6% | 36,2 k € | -21.5% | 46,1 k € |
| Net result | 34,5 k € | +21.2% | 28,5 k € | +24.9% | 22,8 k € | -36.0% | 35,6 k € | -2.0% | 36,3 k € | +1100% | 3 k € | -93.3% | 45,3 k € | +322% | -20,4 k € | -10.3% | -18,5 k € | -281% | 10,2 k € | -74.0% | 39,2 k € | +307% | -19 k € | +62.3% | -50,3 k € | -108% | 599,1 k € | +2031% | -31 k € | -376% | 11,2 k € | +982% | 1 k € | -88.4% | 9 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||
| Equity | 748,3 k € | +4.8% | 713,7 k € | +4.2% | 685,3 k € | +3.4% | 662,4 k € | +0.1% | 661,8 k € | +6.6% | 621 k € | +0.5% | 618 k € | +7.9% | 572,7 k € | -3.4% | 593,1 k € | -3.0% | 611,6 k € | +1.7% | 601,4 k € | +7.0% | 562,2 k € | -3.3% | 581,2 k € | -8.0% | 631,5 k € | +1850% | 32,4 k € | -48.9% | 63,4 k € | +21.6% | 52,2 k € | +2.0% | 51,1 k € |
| Total assets | 797,5 k € | -0.4% | 800,3 k € | +0.9% | 793,2 k € | -0.3% | 795,6 k € | +0.2% | 793,9 k € | +25.9% | 630,7 k € | -5.4% | 667 k € | +2.8% | 648,6 k € | -6.7% | 695,4 k € | +0.8% | 689,9 k € | +3.7% | 665,1 k € | +8.7% | 611,7 k € | -0.5% | 614,9 k € | -22.4% | 792,3 k € | -13.2% | 912,5 k € | -1.1% | 922,3 k € | -1.3% | 934 k € | +1.7% | 918 k € |
| Cash | 4 k € | -44.4% | 7,2 k € | +974% | 668,6 € | -96.7% | 20,1 k € | -32.3% | 29,7 k € | +82266% | 36 € | -99.9% | 33,7 k € | +2419% | 1,3 k € | +270% | 361 € | -98.6% | 26,4 k € | -12.0% | 30 k € | +62.8% | 18,4 k € | -91.6% | 219,8 k € | -0.5% | 221 k € | +3977% | 5,4 k € | -34.5% | 8,3 k € | +18.8% | 7 k € | -1.8% | 7,1 k € |
| Debts | 49,2 k € | -43.1% | 86,6 k € | -19.8% | 108 k € | -18.9% | 133,1 k € | +0.7% | 132,1 k € | +1268% | 9,7 k € | -80.3% | 49 k € | -35.5% | 75,9 k € | -25.8% | 102,4 k € | +30.7% | 78,3 k € | +22.9% | 63,7 k € | +28.8% | 49,5 k € | +46.7% | 33,8 k € | -78.9% | 159,8 k € | -81.8% | 875,8 k € | +5.9% | 827,2 k € | -4.6% | 866,9 k € | +0.6% | 861,4 k € |
Estimate
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 5 ended
Active mandates
Caroline Verlinden
ActiveActive
Ended mandates
De Zandschel BV
EndedRoeland Moorkens
EndedRoeland Moorkens
EndedDirk Moorkens
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
DE ZANDSCHEL● Active | 0681.459.444 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/07/2026 | 23/06/2025 | 19/07/2024 | 10/05/2023 | 06/07/2022 | 09/08/2021 |
| General meeting | 12/05/2026 | 16/06/2025 | 30/06/2024 | 03/05/2023 | 06/06/2022 | 07/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 12/05/2026 | 15/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 16/06/2025 | 23/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 30/06/2024 | 19/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 03/05/2023 | 10/05/2023 | Dutch | |
| Abridged model | 31/12/2021 | 06/06/2022 | 06/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 07/06/2021 | 09/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 01/06/2020 | 29/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 03/06/2019 | 27/09/2019 | Dutch | |
| Micro model | 31/12/2017 | 04/06/2018 | 28/09/2018 | Dutch | |
| Micro model | 31/12/2016 | 05/06/2017 | 25/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 06/06/2016 | 30/09/2016 | Dutch | |
| Abridged model | 31/12/2014 | 01/06/2015 | 26/09/2015 | Dutch | |
| Abridged model | 31/12/2013 | 02/06/2014 | 28/09/2014 | Dutch | |
| Abridged model | 31/12/2012 | 03/06/2013 | 20/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 04/06/2012 | 28/09/2012 | Dutch | |
| Abridged model | 31/12/2010 | 06/06/2011 | 31/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 07/06/2010 | 05/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 01/06/2009 | 05/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 02/06/2008 | 28/08/2008 | Dutch | |
| Abridged model | 31/12/2006 | 04/06/2007 | 02/07/2007 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 5 ended
Active mandates
Caroline Verlinden
ActiveActive
Ended mandates
De Zandschel BV
EndedRoeland Moorkens
EndedRoeland Moorkens
EndedDirk Moorkens
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates05/05/2021ONTSLAGEN - BENOEMINGEN
- Mandates20/02/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - DOEL - ONTSLAGEN - BENOEMINGEN
- Registered office20/07/2015MAATSCHAPPELIJKE ZETEL
- Other22/08/2003RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202534,5 k €↑
- 2024Annual accounts 202428,5 k €↑
- 2023Annual accounts 202322,8 k €↓
- 2022Annual accounts 202235,6 k €↓
- 2021Annual accounts 202136,3 k €↑
- 2019Name changePharmalijn
- 2018Annual accounts 20183 k €↓
- 2017Annual accounts 201745,3 k €↑
- 2016Annual accounts 2016-20,4 k €↓
- 2015Annual accounts 2015-18,5 k €↓
- 2014Annual accounts 201410,2 k €↓
- 2013Annual accounts 201339,2 k €↑
- 2012Annual accounts 2012-19 k €↑
- 2011Annual accounts 2011-50,3 k €↓
- 2010Annual accounts 2010599,1 k €↑
- 2009Annual accounts 2009-31 k €↓
- 2008Annual accounts 200811,2 k €↑
- 2007Annual accounts 20071 k €↓
- 2006Annual accounts 20069 k €
- 2006Name changePHARMALIJN HOLDING
- 14/08/2003IncorporationPrivate limited company